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Adipose tissue is a dynamic organ that hydrolyzes and
synthesizes triglycerides. Lipolysis of adipocyte triglycerides
and the release of FFAs into the bloodstream provides
energy for normal body organ system function during
postabsorptive conditions and is critical for survival during
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periods of starvation. However, an increased rate of lipolysis
and plasma FFA concentrations can cause multi-organ insulin resistance (1). In contrast, an increased capacity of
adipocytes to produce FFAs from glucose (i.e., de novo lipogenesis) is associated with insulin sensitivity (2–4). Excessive accumulation of triglycerides in adipose tissue, which
occurs in people with obesity, is associated with metabolic
abnormalities and diseases, including insulin resistance,
atherogenic dyslipidemia, nonalcoholic fatty liver disease, and type 2 diabetes (5). These findings underscore
the importance of the balance between adipocyte triglyceride lipolysis and synthesis in regulating body fat mass and
metabolic health.
For adipocytes to store lipid, FAs are sequentially esterified to a glycerol backbone to synthesize the primary form
of stored energy, triglyceride. There are two major pathways for triglyceride synthesis. The canonical pathway for
FA incorporation of triglyceride begins with glycerol3-phosphate and through sequential acylation and dephosphorylation of the glycerol backbone, triglyceride is
formed. Deficiencies in specific steps in this pathway are
known to result in lipodystrophy and failure of adipocytes
to terminally differentiate (6). The other pathway of triglyceride synthesis involves the acylation of monoacylglycerol (MG) by monoacylglycerol acyltransferase (MGAT)
enzymes to form diacylglycerol (DG) (6). Relative to the
glycerol-3-phosphate pathway, the role of the MGAT pathway in contributing to adipocyte lipogenesis and lipid
metabolism is much less well understood. Three related
MGAT-encoding genes have been identified in humans;
namely, MOGAT1, MOGAT2, and MOGAT3, which encode MGAT1, MGAT2, and MGAT3. In mice, Mogat1
and Mogat2 encode MGAT1 and MGAT2, but the mouse

Abbreviations: Adn-Mogat1/, fat-specific Mogat1 knockout mouse;
DG, diacylglycerol; DGAT, diacylglycerol acyltransferase; eWAT, epidydimal
white adipose tissue; IBMX, 3-isobutyl-1-methylxanthine; iWAT, inguinal
white adipose tissue; MG, monoacylglycerol; MAO, metabolically-normal
obesity; MEF, mouse embryonic fibroblast; MGAT1, monoacylglycerol acyltransferase 1; MNO, metabolically-abnormal obesity; p-Plin1, phosphorylated perilipin 1; sBAT, subscapular brown adipose tissue; siControl,
small interfering RNAs directed against a nontargeting sequence;
siMogat1, small interfering RNAs directed against Mogat1.
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Abstract Adipocyte triglyceride storage provides a reservoir
of energy that allows the organism to survive times of
nutrient scarcity, but excessive adiposity has emerged as
a health problem in many areas of the world. Monoacylglycerol acyltransferase (MGAT) acylates monoacylglycerol to
produce diacylglycerol; the penultimate step in triglyceride
synthesis. However, little is known about MGAT activity in
adipocytes, which are believed to rely primarily on another
pathway for triglyceride synthesis. We show that expression
of the gene that encodes MGAT1 is robustly induced during
adipocyte differentiation and that its expression is suppressed in fat of genetically-obese mice and metabolicallyabnormal obese human subjects. Interestingly, MGAT1
expression is also reduced in physiologic contexts where
lipolysis is high. Moreover, knockdown or knockout of
MGAT1 in adipocytes leads to higher rates of basal adipocyte lipolysis. Collectively, these data suggest that MGAT1
activity may play a role in regulating basal adipocyte FFA
retention.—Liss, K. H. H., A. J. Lutkewitte, T. Pietka, B. N.
Finck, M. Franczyk, J. Yoshino, S. Klein, and A. M. Hall.
Metabolic importance of adipose tissue monoacylglycerol
acyltransferase 1 in mice and humans. J. Lipid Res. 2018. 59:
1630–1639.

to remove LacZ and Neo cassettes and generate mice harboring
the conditional floxed allele (Fig. 5A). Mogat1 floxed mice were
then crossed with hemizygous C57BL/6 mice expressing Cre under
the Adiponectin promoter to create Adn-Mogat1 mice. Littermate
mice not expressing Cre (fl/fl mice) were used as control mice in
all experiments. All animal experiments were approved by the
Institutional Animal Care and Use Committee of Washington
University.

Assessment of plasma metabolites
Nonesterified FFAs were measured using enzymatic assays
(Wako Diagnostics, Mountain View, CA). Plasma triglyceride and
cholesterol were measured using Infinity colorimetric assay kits
(Thermo Fisher Scientific, St. Peters, MO). Plasma insulin was
measured using an immunoassay (Singulex, Alameda, CA) by the
Core Laboratory of the Diabetes Research Center at Washington
University.

Phenomaster metabolic profiling
Indirect calorimetry, energy expenditure, spontaneous activity,
and food consumption were measured in Phenomaster TSE®
cages as previously reported (18). Data was measured and collected at 10 min intervals for 24 h. Prior to measurements, mice
Table 1. Primer sequences used for quantitative real-time PCR
Mouse Genes

Atf3
Ccl2
Cd68
F4/80
Fasn
Grp78
Il1b

MATERIALS AND METHODS

Il4
Il10

Animals
Male mice were used in all studies. Ob/ob (catalog number
000632), ob/+, db/db (catalog number 000697), db/+, and
C57BL/6J (catalog number 000664) mice were obtained from
Jackson Laboratory (Bar Harbor, ME). All mice were maintained
on LabDiet 5053. Ob/Ob, control littermates, and C57BL/6J mice
were sacrificed at 12 weeks of age. db/db and control littermates
were sacrificed at 14 weeks of age. All animal experiments were
approved by the Animal Studies Committee of Washington University School of Medicine.
/

Generation of Adn-Mogat1

mice

C57BL/6 mouse embryonic stem cells containing a “knockout
first” allele of Mogat1 were obtained from the Knockout Mouse
Project (Project ID CSD35789). This construct contains a targeted
allele of Mogat1 containing inserted cassettes for promoter-driven
LacZ and Neo cDNAs flanked by frt sites upstream of exon 4 of
the Mogat1 gene, which is flanked by LoxP sites. Propagated ES
cells were injected into developing embryos and then implanted
into pseudopregnant females. Chimeric offspring were mated to
establish germline transmission. Resulting heterozygous offspring
were mated with C57BL/6 mice expressing Flp recombinase
in a global manner (chicken  actin promoter-driven transgenic)

Mogat1
Mogat2
Pparg
Nos2
Slc2a4
Xbp1t
Xbp1s
36B4
Human Genes

FASN
MOGAT1
PPARG
SLC2A4

Primer Sequence (5′-3′)

For: CAG ACC CCT GGA GAT GTC AGT
Rev: TTC TTG TTT CGA CAC TTC GCA
For: TTA AAA ACC TGG ATC GGA ACC AA
Rev: GCA TTA GCT TCA GAT TTA CGG GT
For: CCT TGA CCT GCT CTC TCT AAG G
Rev: CTG GTA GGT TGA TTG TCG TCT G
For: CCT GAT GGT GAG AAA CCT GA
Rev: CCC CAG GAA ACT CCA GAT AA
For: GTC TGG AAA GCT GAA GGA TCT C
Rev: TGC CTC TGA ACC ACT CAC AC
For: ACC CCG AGA ACA CGG TCT T
Rev: GCT GCA CCG AAG GGT CAT T
For: GTG TGT GAC GTT CCC ATT AGA C
Rev: GTC GTT GCT TGG TTC TCC TT
For: GGTCTCAACCCCCAGCTAGT
Rev: GCCGATGATCTCTCTCAAGTGAT
For: GGC GCT GTC ATC GAT TTC TCC CC
Rev: AGC TCT GTC TAG GTC CTG GAG TCC
For: TGG TGC CAG TTT GGT TCC AG
Rev: TGC TCT GAG GTC GGG TTC
For: TGG GAG CGC AGG TTA CAG A
Rev: CAG GTG GCA TAC AGG ACA GA
For: AAG ACC CAG CTC TAC AAC AGG C
Rev: GCC AAC AGC TTC TCC TTC TCG G
For: GGT TTG AAA CTT CTC AGC CAC C
Rev: TTC TCC GTT CTC TTG CAG TTG A
For: CTG TCG CTG GTT TCT CCA A
Rev: CTG CTC TAA AAG GGA AGG TGT C
For: CAG ACT ACG TGC GCC TCT GC
Rev: CTT CTG GGT AGA CCT CTG GG
For: TCT GCT GAG TCC GCA GCA GG
Rev: CTC TAA GAC TAG AGG CTT GG
For: GCA GAC AAC GTG GGC TCC AAG CAG AT
Rev: GGT CCT CCT TGG TGA ACA CGA AGC CC
Primer Sequence (5′-3′)

For: TGG AAG TCA CCT ATG AAG CCA
Rev: ACG AGT GTC TCG GGG TCT C
For: AAA GTG TGT CCT ACA TGG TAA GC
Rev: TGA TCC TTC AGG GTT GTC AGT
For: ATA AAG TCC TTC CCG CTG AC
Rev: CAC CTC TTT GCT CTG CTC CT
For: GCC CCA CAG AAG GTG ATT GA

MGAT1 in adipocyte metabolism
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Mogat3 is a pseudogene and not analogous to human
MOGAT3 (7–9). Data from a series of studies have shown
that MGAT2 is important for enterocyte absorption of
ingested fat (7, 10–12). MGAT1 is not well-expressed in
intestine, but MGAT1-mediated MGAT activity may be
important in the pathogenesis of obesity-related hepatic
insulin resistance (13–15). Some recent work using MGAT1
constitutive knockout mice has called into question
whether MGAT1 is a significant contributor to tissue MGAT
activity (16). However, acute knockdown of MGAT1 in steatotic liver reduced MGAT activity and promoted an insulin-sensitive phenotype (13). Other than in intestine and
liver, the metabolic effects of MGAT enzymes have been
little studied. For example, although MGAT expression
and activity have been detected in adipose tissue (8, 17), its
contribution to adipocyte lipid metabolism is unclear.
Because adipose tissue triglyceride synthetic rates are extremely high and Mogat1 is known to be transcriptionallyactivated by PPAR (13, 14), the master regulator of
adipogenesis, we sought to test the hypothesis that Mogat1
is also expressed in adipocytes and regulates adipocyte
lipid metabolism. We found that Mogat1, which encodes
the MGAT1 enzyme, is robustly induced in adipocytes
during the process of adipogenesis. Moreover, Mogat1 expression is inversely correlated with lipolytic rates, and suppression of Mogat1 expression increases basal lipolytic
activity. In addition, adipose tissue MOGAT1 expression is
greater in people with obesity who are metabolically normal than those who are metabolically abnormal. Together,
these data suggest that MGAT1 is involved in both triglyceride production and lipolysis, and demonstrate increased
adipose tissue MOGAT1 expression is associated with metabolic health in people.

were housed individually and trained for 1 day in metabolic cages
before metabolic measurements were collected. Mean relative
VO2 (expressed in ml/kg/min) and respiratory quotient (RQ; calculated as VCO2/VO2) were determined for 24 h.

Body composition measurements
Body composition was determined using an EchoMRI 3-in-1
instrument (Echo Medical Systems). Free water mass, lean mass,
and fat mass were all determined on Adn-Mogat1 KO and WT littermates after 10 weeks on standard chow. Free water mass was
less than 0.1 g for all mice.

Adipocyte differentiation of MEFs, human preadipocytes,
and 3T3-L1 fibroblasts

siRNA-mediated Mogat1 knockdown in differentiated
3T3-L1 adipocytes
ON-TARGETplus, SMARTpool siRNA directed against Mogat1
(siMogat1) and a nontargeting negative control (siControl) were
purchased from Dharmacon (Lafayette, CO). Day 6, fully differentiated 3T3-L1 adipocytes were transfected with siMogat1 or siControl reagents with DarmaFECT 1 (Lafayette, CO) according to the
manufacturer’s protocol. Adipocytes were treated with siRNAs for
48 h before RNA, protein, or lipolysis assays were performed.

Fully differentiated adipocytes were used for lipolysis studies.
Adipocytes were incubated in Krebs-Ringer-bicarbonate HEPES
buffer, pH 7.4) containing 4 mg/ml fatty acid free BSA and
2.5 mM glucose (with or without 1 µM isoproterenol) at 37°C for
2 h. Lipolysis was evaluated by measuring the amount of glycerol
and FFAs released into the media. Glycerol was determined
by a glycerol assay kit (Sigma). FFAs were quantified with a
NEFA kit (Wako Diagnostics) according to the manufacturer’s
instructions.

Primary adipose tissue explants, lipolysis, and FFA
re-esterification
Epididymal adipose tissue was harvested, minced under sterile
conditions, and cultured for 48 h in M199 (Sigma) containing
insulin (Sigma, 1.5 g/ml) and dexamethasone (Sigma, 25 nM)
at 37°C in the presence of 5% CO2. Immediately prior to the
lipolysis assay, tissue pieces were washed to remove insulin and portioned (30–50 mg per well) into 12-well plates containing 0.25 ml
of assay medium (Krebs-Ringer Buffer, pH 7.4, supplemented
with fatty acid free BSA (Sigma, 4%), glucose (Sigma, 5 mM), adenosine (Sigma, 200 M), adenosine deaminase (Roche, 1U/
ml), and N6-(L-2-Phenylisopropyl)adenosine (40 nM, Sigma). To
begin the lipolysis assay, wells were supplemented with an additional 250 l of assay medium either without (basal) or with
(stimulated) 0.5 M isoproterenol. The lipolysis assay was conducted at 37°C (5% CO2) for 2 h. Aliquots of conditioned media
were collected at 1 and 2 h and lipolysis evaluated by measuring
the amount of glycerol and FFAs released into the media. Glycerol was determined by a glycerol assay kit (Sigma). FFAs were
quantified with a NEFA kit (Wako Diagnostics) according to the
manufacturer’s instructions.
The FFA re-esterification rate in primary epididymal adipose
tissue explants was quantified using the “balance” method described by Vaughan (20). This method is based on the following

Fig. 1. Mogat1 is induced during differentiation of
mouse and human adipocytes. A: Expression of the
indicated genes in MEF-derived adipocyte precursor
cells after 0, 2, 4, 6, or 8 days of culture in differentiation medium as described in the Materials and Methods. Data are presented as mean ± SEM, n = 5 per
group, *P < 0.05 versus D0 fibroblasts. B: Expression of
the indicated genes in human subcutaneous adipocyte
precursor cells after 0, 2, 4, 6, or 8 days of culture in
differentiation medium as described in the Materials
and Methods. Data are presented as mean ± SEM, *P <
0.05 versus D0 fibroblasts. C: Western blot analysis for
MGAT1 proteins in 3T3-L1 fibroblasts and differentiated adipocytes (D) MGAT enzymatic activity in 3T3L1 fibroblasts or differentiated adipocytes. Data are
presented as mean ± SEM, n = 5 per group, *P < 0.05
versus fibroblasts.
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Primary mouse embryonic fibroblasts (MEFs) were isolated from
14-day-old mouse embryos as previously described (19). Human
subcutaneous preadipoctyes were purchased from Lonza. 3T3-L1
fibroblasts were obtained from ATCC. Briefly, cells were seeded in
12-well plates and propagated to confluence. Two days postconfluence, differentiation was initiated using DMEM containing
10% FBS, 175 nM insulin, 250 nM dexamethasone, and 0.5 mM
3-isobutyl-1-methylxanthine (IBMX). Two days after initiation, the
medium was replaced with a maintenance medium (DMEM containing 10% FBS and 175 nM insulin). Fresh maintenance medium was replaced every 2 days thereafter.

Lipolysis in cultured cells

formula: re-esterified FFA (nmol/mg tissue/hr) = 3 × released
glycerol (nmole/mg/hr)  released FFA (nmol/mg/hr). The
formula accounts for total change in both FFA and glycerol in
the system (media and cell-associated). Glycerol was determined by a glycerol assay kit (Sigma). FFAs were quantified
with a NEFA kit (Wako Diagnostics) according to the manufacturer’s instructions.

MGAT enzymatic assays

Mogat1 is induced during differentiation of mouse and
human adipocytes
We evaluated the expression and activity of Mogat1 during adipocyte differentiation. Mouse embryonic fibroblasts
and human subcutaneous preadipocytes were cultured in
the presence of adipocyte differentiation cocktail, and the
expression of Mogat1 and MOGAT1 was evaluated as the
cells differentiated into adipocytes. The expression of both
Mogat1 and MGAT1 was very low in both fibroblasts and
preadipocytes, but increased markedly as mouse and human cells attained their differentiated phenotype (Fig. 1A, B).
The timing of this induction coincided with an increased
expression of PPAR (Fig. 1A, B), a master regulator of

Downloaded from www.jlr.org at Washington Univ Medical Library, on September 6, 2018

MGAT assays were performed to measure initial activity
rates as previously described (13). Adipocytes and fibroblasts
were homogenized in 50 mM Tris-HCl (pH 7.4), 1 mM EDTA,
and 0.25 M sucrose. Monoolein was dried down and reconstituted in assay buffer containing 5 mM MgCl2, 1.25 mg/ml BSA,
200 mM sucrose, 100 mM Tris-HCl (pH 7.4), 25 M [14C]oleoylCoA, and 200 M sn-2-oleoylglycerol. Fifty micrograms of protein were used to initiate each reaction and incubated for 5
min. The reaction was terminated by the addition of 50 ml 1%
phosphoric acid. Lipids were extracted with 0.300 ml CHCl3/
MeOH (2:1 vol/vol) and separated by TLC with hexane/ethyl
ether/acetic acid (80:20:1 vol/vol/vol). Lipids were extracted
and separated on Linear-K preadsorbent TLC plates. The spots
corresponding to DG and triacylglycerol were scraped from the
TLC plates and 14C-radioactivity was quantified by a scintillation
counter.

RESULTS

mRNA isolation and gene expression analyses
Total adipose tissue RNA was extracted with RNA-BEE (Iso-Tex
Diagnostics, Friendswood, TX) according to the manufacturer’s
instructions. First-strand cDNA synthesis was performed using ABI
reagents, and quantitative real-time RT-PCR was performed using
the ABI PRISM 7500 sequence detection system (Applied Biosystems, Foster City, CA) with Power SYBR green. Arbitrary units of
target mRNA were corrected to the corresponding level of the
36B4 mRNA. The sequences of the primers used in these studies
are found in Table 1.

Western blot analyses
For Western blot analyses, protein extracts were obtained from
tissue by using the following lysis buffer containing a protease inhibitor cocktail: 10 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM
EDTA, 0.1% sodium deoxycholate, and 1% Triton X-100. Antibody against MGAT1 was generated by Proteintech by using the
synthetic peptide that corresponds to C-terminal amino acids 322335 of mouse MGAT1.

Assessments in human subjects
Subcutaneous abdominal adipose tissue samples obtained
from 22 men and women with obesity (mean ± SD, BMI 40.6 ± 9.2
kg/m2), as part of their participation in a previous study that evaluated the metabolic effects of weight gain (3), were used to evaluate MOGAT1 and MOGAT2 expression. Adipose tissue samples
were obtained during the basal period of a hyperinsulinemiceuglycemic clamp procedure, which was conducted in conjunction with the infusion of 6,6-2H2]glucose and [U-13C]palmitate
tracers (Cambridge Isotope Laboratories) to assess insulin glucose
rate of disappearance from plasma during basal conditions and
insulin infusion and FFA rate of appearance in plasma during basal
conditions, as previously described (3).

Statistical analysis
Statistical comparisons were made using t-test or ANOVA
where appropriate. Unless specified, all data are presented as
mean ± SEM, with statistically significant difference defined as
P < 0.05.

Fig. 2. Mogat1 expression is decreased in adipose tissue of ob/ob
and db/db mice and suppressed by lipolytic stimuli. A: Expression of
indicated genes in adipose tissue of ob/+ vs ob/ob. Data are presented
as mean ± SEM, n = 6 per group, *P < 0.05 versus ob/+ mice. B: Expression of indicated genes in adipose tissue of db/+ versus db/db
mice. Data are presented as mean ± SEM, n = 6 per group,
*P < 0.05 versus ob/+ mice.
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adipocyte differentiation, and the expression of lipin-1, a key
enzyme in the glycerol-3-phosphate pathway of triglyceride
synthesis (Fig. 1A, B). Differentiation also caused an increase in the expression of Mogat2 in the mouse adipocytes,
but this increase was very small (data not shown). MOGAT2
was undetectable in human adipocytes (data not shown).
The increase in gene expression of Mogat1 was associated
with an increase in MGAT1 levels, determined by using
Western blot analysis (Fig. 1C). In addition, MGAT activity
was much greater in mature adipocytes than in fibroblasts
(Fig. 1D), demonstrating that the increased expression of
Mogat1 results in a functional increase in enzyme activity.
Together, these data indicate that the expression of
MGAT1 and MGAT activity is markedly increased during
adipocyte differentiation.

Adipose tissue Mogat1 expression is suppressed by
lipolytic stimuli
We examined the expression of Mogat1 in mice after a
prolonged (36 h) fast, which is a potent lipolytic stimulus.
Fasting caused a 90% reduction in the expression of
Mogat1 in epididymal adipose tissue of C57BL/6J mice

Mogat1 knockdown increases basal FFA release
To test whether suppressing Mogat1 would affect lipolytic rates, we treated differentiated adipocytes with siRNA
against Mogat1 (siMogat1) or negative control siRNA
(siControl). Forty-eight hours later, Mogat1 expression was
reduced by 90% compared with siControl-treated cells,
while Mogat2 expression was unaffected by siMogat1 treatment (Fig. 4A). Differentiated 3T3-L1s (treated with the
siControl or siMogat1 for 48 h) were serum-starved for 4 h
before measuring basal and -adrenergic stimulated-lipolysis
(10 M isoproterenol) for 1 h. A 90% reduction in expression of Mogat1 increased adipocyte FFA release in
basal conditions (Fig. 4B), but stimulated lipolytic activity
was not affected. Expression and stimulated phosphorylation of the adipocyte’s major lipolytic machinery; namely,
phosphorylated hormone sensitive lipase, phosphorylated perilipin 1, and adipose tissue triglyceride lipase,
was not affected by knockdown of Mogat1 (Fig. 4C),
suggesting a direct effect of MGAT1 enzymatic activity on
FFA re-esterification.

Fig. 3. Mogat1 expression is suppressed by lipolytic
stimuli. A: Expression of indicated genes in adipose
tissue of mice during fasted conditions and upon
refeeding. Data are presented as mean ± SEM, n = 6
per group, *P < 0.05 versus ad libitum (fed). B: Mogat1
expression in mice following injection of isoproterenol (25 mg/kg IP). Data are presented as mean ±
SEM, n = 5 per group, *P < 0.05 versus vehicle. C: Mogat1 expression in 3T3-L1 cells treated with insulin
(100nM), isoproterenol (10M), or isobutylmethylxanthine (IBMX, 0.5nM) for 24 h. Data are presented
as mean ± SEM, n = 5 per group, *P < 0.05 versus
control.
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Mogat1 expression is decreased in adipose tissue of ob/ob
and db/db mice
We sought to determine whether the expression of
Mogat1 might be regulated in adipose tissue in mouse models of metabolically abnormal obesity. Compared with ob/+
mice, ob/ob mice had a much lower expression of Mogat1 in
epididymal adipose tissue (Fig. 2A). Mogat1 expression was
also markedly decreased in db/db mice compared with db/+
mice (Fig. 2B). Consistent with a role for PPAR in regulating Mogat1, the expression of Pparg was significantly decreased in ob/ob as well as db/db mice. Furthermore, the
expression of other lipogenic genes such as fatty acid synthase (Fasn) and the glucose transporter, Slc2a4 (GLUT4),
was also significantly lower in the ob/ob and db/db mice than
in ob/+ and db/+ mice.

(Fig. 3A). Upon refeeding for 12 h after a 24 h fast, Mogat1
expression returned to levels observed in the fed state. The
expression of Fasn and Slc2a4 was also suppressed in adipose tissue by fasting and restored by refeeding. However,
Pparg expression was not regulated in parallel. We also assessed the effects of a  agonist (isoproterenol) on Mogat1
expression. Six hours after administration of isoproterenol,
Mogat1 expression was markedly decreased in epididymal
adipose tissue of mice (Fig. 3B). To examine whether these
effects were direct, we treated 3T3-L1 adipocytes for 24 h
with isoproterenol or IBMX, which both activate protein
kinase A and lipolysis. Both isoproterenol and IBMX reduced Mogat1 expression (Fig. 3C). In contrast, insulin
treatment, which inhibits lipolytic activity, resulted in
increased Mogat1 expression (Fig. 3C). These data demonstrate a negative relationship between adipocyte lipolytic
rate and Mogat1 expression.

Adipocyte-specific Mogat1 knockout mice have increased
basal rates of FFA release
To further confirm our in vitro findings of Mogat1 knockdown, we generated fat-specific Mogat1 knockout mice using
/
Cre-LoxP mediated methods (Adn-Mogat1 ) (Fig. 5A).
These mice were viable and did not display an outward
phenotype at baseline. Adn-Mogat1/ mice had significantly decreased expression of Mogat1 in all examined
fat depots, but expression levels were not altered in the
stomach or the liver (Fig. 5B). Western blot analysis also
demonstrated loss of MGAT1 protein in adipose tissue of
the knockout mice, which was accompanied by decreased
MGAT activity (Fig. 5C).

Adipose tissue biology in people with metabolically-normal
and metabolically-abnormal obesity
We next sought to determine whether the results from
the studies conducted in mice apply to humans by evaluating subcutaneous adipose tissue MOGAT1 expression and
the relationship between adipose tissue MOGAT1 expression and basal lipolytic activity in 22 men and women with
either metabolically-normal obesity (MNO, n = 10) or metabolically-abnormal obesity (MAO, n = 12) (Table 4). The
classification of MNO and MAO was determined by the
glucose infusion rate required to maintain euglycemia
during a hyperinsulinemic-euglycemic clamp procedure,
based on the upper and lower tertile of values we obtained
in previous studies; those with a glucose infusion rate 10.5
mg/kg fat-free mass/min were defined as MNO and those
with a glucose infusion rate 6.9 mg/kg fat-free mass/min
were defined as MAO. Subjects with MAO had lower subcutaneous adipose tissue expression of MOGAT1 than those
with MNO (Fig. 7A). Adipose tissue MOGAT2 expression
was undetectable in all subjects (data not shown). In concert with the data obtained in our rodent models of obesity
MGAT1 in adipocyte metabolism
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Fig. 4. Mogat1 knockdown in differentiated 3T3-L1 adipocytes
leads to increased basal FFA release. A: Mogat1 knockdown using
siRNA in differentiated adipocytes. Data are presented as mean ±
SEM, n = 5 per group, *P < 0.05 versus siControl. B: Mogat1 knockdown in differentiated adipocytes leads to increased FFA release
during basal lipolysis, but not isoproterenol stimulated lipolysis.
Data are presented as mean ± SEM, n = 5 per group, *P < 0.05 versus siContol. C: Western blots for lipolytic machinery, p-HSL, total
HSL, p-PLIN, ATGL, and tubulin.

At 10 weeks old, male Adn-Mogat1/ mice fed a standard low fat chow weighed the same as their WT littermates
(Fig. 5D). To determine total body composition, mice were
subjected to noninvasive EchoMRI measurements. AdnMogat1/ mice and WT littermates had similar total lean
mass, but Adn-Mogat1/ mice had significantly less total
fat mass compared with age-matched littermates (Fig. 5D).
These measures were confirmed at euthanasia; epididymal
and inguinal fat pads from the Adn-Mogat1/ mice were
significantly smaller than control littermates, while the subscapular brown fat pad was not different (Fig. 5E). Interestingly, liver triglyceride levels were not significantly affected,
but trended lower, in the Adn-Mogat1/ mice (Fig. 5F).
Blood glucose was significantly decreased in the AdnMogat1/ mice after a 4 h fast (Table 2), whereas plasma
lipids (triglycerides, FFAs, and cholesterol) were unchanged
(Table 2). Interestingly, despite having smaller fat pad
mass, the Adn-Mogat1/ mice did not display significant
differences in food intake, O2 consumption, CO2 production, respiratory exchange ratio, or energy expenditure during a 24-h assessment (Table 3).
Lipolytic rates were assessed in isolated adipose tissue explants from Adn-Mogat1/ mice and matched littermate
controls. Although isoproterenol-stimulated adipose tissue
lipolytic rate was not different between groups, the basal
rate of FFA release from Mogat1 knockout mice was significantly increased compared to control mice (Fig. 5G). Moreover, the FFA re-esterification rate was significantly decreased
in the epididymal fat pads from Adn-Mogat1 mice (Fig. 5H).
These data are again consistent with adipocyte MGAT1 playing a role in the recycling of FFAs and MG during conditions
of low lipolytic flux. Interestingly, unlike the previous report
showing that diacylglycerol acyltransferase (DGAT) deficiency led to increased endoplasmic reticulum stress due to
the increase in lipolytic products (21), we found no evidence
for ER stress in fat pads of Adn-Mogat1/ mice and the expression of some of these genes was actually reduced (Fig. 6).
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Fig. 5. Adipocyte-specific Mogat1 knockout mice have increased basal rates of FFA release. A: Breeding Schematic for the creation of AdnMogat1/ mice. B: Mogat1 mRNA expression of profile of Adn-Mogat1 mice and WT littermates. Data are presented as mean ± SEM, n = 6
per group, *P < 0.05 versus WT littermates. eWAT, epididymal adipose tissue; iWAT, inguinal adipose tissue; sBAT, subscapular brown adipose
tissue. C: Western blot depicts loss of MGAT1 protein in epididymal fat pads. MGAT activity is reduced in epididymal fat pads from AdnMogat1/ mice. Data are presented as mean ± SEM, n = 5 per group, *P < 0.05 versus WT littermates. D: Body weight and composition of
10-week-old, chow-fed male Adn-Mogat1 mice and WT littermates. Data are presented as mean ± SEM, n = 9 per group, *P < 0.05 versus WT
littermates. E: Weight of eWAT, iWAT, and sBAT from 10-week-old, chow-fed Adn-Mogat1 mice and WT littermates. Data are presented as
mean ± SEM, n = 9 per group, *P < 0.05 versus WT littermates. F: Hepatic triglyceride content for 10-week-old, chow-fed Adn-Mogat1 mice
and WT littermates. Data are presented as mean ± SEM, n = 9 per group. G: Basal FFA release is increased from epididymal adipose tissue
fragments from Adn-Mogat1/ mice under basal conditions but not isoproterenol (Iso) stimulated conditions. Data are presented as mean
± SEM, n = 6 per group, *P < 0.05 versus WT littermates. H: FFA re-esterification rate is reduced in epididymal fat pads from Adn-Mogat1/
mice compared with WT littermates. Data are presented as mean ± SEM, n = 5 per group, *P < 0.05 versus WT littermates.
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TABLE 2. Plasma metabolites from 10-week-old male WT and
Adn-Mogat1/ mice littermates after a 4 h fast

Glucose (mg/dl)
Insulin (ng/ml)
Free fatty acids (M)
Triglycerides (mg/dl)
Cholesterol (mg/dl)

fl/fl

Adn-Mogat1/

P

170 ± 3
0.56 ± 0.05
0.42 ± 0.03
71 ± 6
78 ± 6

155 ± 6
0.69 ± 0.13
0.38 ± 0.04
67 ± 5
83 ± 5

0.045
0.37
0.17
0.51
0.15

n = 9 per group.
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and insulin resistance, adipose tissue expression of other
lipogenic genes, including PPARG, FASN, and SLC2A4, was
lower in subjects with MAO than those with MNO. In addition, adipose tissue MOGAT1 expression was positively correlated with insulin sensitivity, assessed by the rate of
glucose disposal during a hyperinsulinemic-euglycemic
clamp procedure (R = 0.59, P = 0.004) (Fig. 7B), and was
negatively correlated with basal adipose tissue lipolytic activity, assessed as the rate of appearance of FFA into the
bloodstream determined by using a stable isotopically labeled palmitate tracer infusion (R = 0.41, P = 0.04) (Fig.
7C). Overall, these data are consistent with the concept
that MAO in humans is associated with an impaired expression of adipose tissue genes encoding factors that promote
triglyceride storage, and a decrease in adipose tissue
MOGAT1 expression contributes to an increase in basal
adipose tissue lipolytic rate.

DISCUSSION
The initial report on cloning of MGAT1 detected its
expression and activity in adipocytes (8), but very little is
known about the physiologic role of adipocyte MGAT1 activity. Accordingly, we conducted a series of studies in cell
systems, animal models, and human subjects to explore the
metabolic function of adipocyte MGAT activity and its relevance in humans. Our data demonstrate that: 1) mice
lacking Mogat1 in adipocytes have less fat mass than WT
littermates; 2) adipose tissue expression of Mogat1 is suppressed in response to physiologic stimuli that increase adipose tissue lipolytic activity; 3) loss of Mogat1 in adipocytes
increases basal lipolytic rate; and 4) adipose tissue MOGAT1
expression was positively correlated with insulin sensitivity and negatively correlated with adipose tissue lipolytic activity in humans. Together, these data demonstrate
that adipocyte MGAT activity has important physiological
functions in preadipocyte differentiation and lipolysis of

TABLE 3. Energy balance and activity of 10-week-old male WT and
Adn-Mogat1 KO mice fed a chow diet ad libitum over 24 h
fl/fl

Food intake (g/day)
2.3 ± 0.1
3143 ± 110
O2 consumption (ml/h/kg)
CO2 production (ml/h/kg)
2833 ± 124
Respiratory exchange ratio
0.894 ± 0.008
Energy expenditure (kcal/h/kg) 15.5 ± 0.6
Activity counts
295 ± 32
WT, n = 4; KO, n = 4.

Adn-Mogat1/

P

2.2 ± 0.2
3286 ± 157
2967 ± 162
0.895 ± 0.006
16.2 ± 0.8
244 ± 43

0.92
0.49
0.54
0.92
0.50
0.42

Fig. 6. Gene expression of inflammatory markers in WT and AdnMogat1/ mice. Expression of indicated genes in epidydimal adipose tissue of obese human subjects. Data are presented as mean ±
SEM, n = 6 per group, *P < 0.05.

adipocyte triglycerides, and suggest MGAT activity may affect whole body insulin sensitivity.
Our data suggest that Mogat1 is a novel regulator of FFA
release from adipocytes. By using Mogat1 knockdown and
adipocyte specific Mogat1 knockout mice, we demonstrated
that MGAT activity decreased the release of FFAs from adipocytes during basal conditions. We postulate that MGAT
MGAT1 in adipocyte metabolism
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TABLE 4. Characteristics of metabolically normal and metabolically
abnormal obese human subjects

Sex, n (male/female)
Age, y
Body mass index
Body fat mass, %
IHTG content, %
Glucose, mg/dl
Insulin, mU/L
Total-cholesterol, mg/dl
LDL-cholesterol, mg/dl
HDL-cholesterol, mg/dl
Triglyceride, mg/dl

Metabolically
Normal Obese

Metabolically
Abnormal Obese

P

10 (2/8)
48 ± 10
35.1 ± 4.7
45 ± 7
4.7 ± 3.9
97 ± 7
8.9 ± 3.1
170 ± 39
100 ± 28
48 ± 11
108 ± 58

12 (2/10)
39 ± 12
43.5 ± 9.3
48 ± 7
11.6 ± 9.1
99 ± 9
22.5 ± 7.0
164 ± 26
103 ± 19
36 ± 6
121 ± 52

0.062
0.015
0.25
0.047
0.594
0.00002
0.681
0.795
0.010
0.593

Data are mean ± SD. IHTG, intrahepatic triglyceride.

Fig. 7. Adipose tissue biology in people with metabolically-normal and metabolically-abnormal obesity.
A: Expression of indicated genes in subcutaneous adipose tissue of obese human subjects. Data are presented as mean ± SEM, *P < 0.05. B: Subcutaneous
adipose tissue MOGAT1 expression is positively correlated with the whole body glucose disposal rate
during a hyperinsulinemic euglycemic clamp. C: Subcutaneous adipose tissue MOGAT1 expression is inversely correlated with whole body lipolysis before
hyperinsulinemic euglycemic clamp.
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activity promotes FFA re-esterification and this serves to prevent FFA release when lipolytic rates should be low. We did
not identify other effects on lipolytic machinery expression
or phosphorylation status after Mogat1 knockdown, suggesting that an important function of MGAT1 is re-esterifying
the FFAs back into DG to prevent their release. While basal
lipolysis was increased in the setting of Mogat1 knockdown,
stimulated lipolysis was not changed. This is not completely
unexpected and is consistent with our observation that
there is a significant suppression of Mogat1 expression in
mouse models associated with high rates of adipose tissue
lipolytic activity, including fasting, -adrenergic receptor activation, and genetic obesity. Together, these findings suggest
MGAT1 regulates FFA release during both basal and stimulated lipolytic conditions. MGAT1 activity promotes FFA reesterification, effectively minimizing FFA release during basal
lipolytic conditions. However, during stimulated lipolysis,

MGAT1 expression is diminished to promote maximal FFA
efflux from adipocytes. In concert with this observation, it
was recently reported that the final enzyme in the triglyceride
synthesis pathway, DGAT1, also plays a role in FFA recycling
of lipolytic products by acylating DG (21). These results
suggest that these two enzymes work together to oppose
lipolysis in adipocytes.
Although obesity is typically associated with a constellation of metabolic abnormalities, including insulin resistance and dyslipidemia, not all people with obesity become
insulin resistant. Lipid dynamics in adipose tissue may provide an explanation for the differences in the individuals
with MNO versus MAO. Indeed, it has been shown that a
high capacity for both glucose uptake and de novo lipogenesis in adipose tissue is metabolically protective in people
with MNO. On the other hand, individuals with obesityrelated metabolic syndrome or insulin resistance have been
found to have a reduced capacity in adipose tissue to take
up glucose and synthesize FAs from carbohydrates. In the
present study, people with MAO had significantly lower expression of PPARG, FASN, and SLC2A4, which is consistent
with previous reports in adipose tissue of people with MAO.
We also found a significant decrease in MOGAT1 expression
in individuals with MAO compared with those with MNO,
suggesting that individuals with MAO also have diminished
capacity for triglyceride synthesis in adipose tissue. While
the sample size is small, we found MOGAT1 expression in
adipose tissue is positively correlated with insulin sensitivity
and negatively correlated with basal FFA rates of release
into the circulation, assessed by using the hyperinsulinemiceuglycemic clamp procedure. Furthermore, in insulin resistant people, the downregulation of MOGAT1 in adipose
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tissue may contributes to decreased FFA re-esterification
and increased FFA release in the blood stream. Indeed, insulin resistance is associated with increased basal lipolytic
rate and the generation of FFAs (22–24), while partial inhibition of adipose tissue lipolysis can improve glucose metabolism and insulin sensitivity (25–28). However, we did
not detect evidence of insulin resistance in Adn-Mogat1/
mice, which had less fat mass and lower blood glucose than
WT controls. This will need to be examined more thoroughly and under conditions where obesity is promoted.
We found that deletion of MGAT1 in adipocytes led to a
substantial reduction in MGAT enzymatic activity. These
results indicate that MGAT1 protein contributes to overall
MGAT activity in adipose tissue. Our findings are contradictory to those from a recent study conducted in a whole
body Mogat1 knockout mouse (16). That study found there
were no deficits in tissue MGAT activity in global Mogat1/
mice. However, MGAT activity was undetectable in many
tissues that were examined. It is possible the inability to
detect any changes in MGAT activity could be due to compensation by MGAT2. Additional studies are necessary to
address these discrepancies.
In summary, we demonstrate that Mogat1 is robustly induced during adipocyte differentiation and expression of
adipose tissue Mogat1 in mice and MOGAT1 in humans are
suppressed in states of relative insulin resistance and increased lipolytic rates. In addition, our data demonstrate
MOGAT1 is likely involved in regulating FFA re-esterification
into triglyceride and therefore FFA release from adipose tissue. These data collectively demonstrate a novel role for
MGAT activity in regulating adipocyte lipid homeostasis with
potential relevance for our understanding of the physiologic
process of lipolysis and the pathophysiology of obesity.

